Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom

BenzingaFeb 14 15:04 ET

Congressmember Shelley Moore Capito's New Portfolio Holdings

Quiver QuantitativeFeb 14 15:00 ET

If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?

Yahoo FinanceFeb 14 13:00 ET

AbbVie appoints the CEO as the Chairman of the Board, effective July 1.

Biopharmaceutical company AbbVie announced on Friday the appointment of its CEO Robert Michael to succeed Richard Gonzales as Chairman, effective July 1. The company stated that Gonzales, who has served as Chairman since the company's founding in North Chicago, Illinois in 2013, will retire from the Board of Directors on July 1 along with Glenn Tilton, who has long served as the company's lead independent director. Gonzales has been with AbbVie since 2013.

Global market report.Feb 14 10:47 ET

Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger

Yahoo FinanceFeb 14 09:00 ET

Wall Street Today: Trump Assigns Tariff Homework Study, Market Climbs

Kevin TraversFeb 13 16:20 ET